Tayyaba Kiran

Dr. Tayyaba Kiran


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Schizophrenia Research
Verified
Journal Article
Closed access
FNFarooq Naeem
Farooq Naeem
SSSofiya Saeed
Sofiya Saeed
MIMuhammad Irfan
Muhammad Irfan
TKTayyaba Kiran
Tayyaba Kiran
Nasir MehmoodNasir Mehmood
Nasir Mehmood
DKDavid Kingdon
David Kingdon

3 August 2020 in BJPsych Open
Verified
Journal Article
Open access
PDF file
MHMuhammad Ishrat Husain
Muhammad Ishrat Husain
SZSyeda S. Zehra
Syeda S. Zehra
MUMadeha Umer
Madeha Umer
TKTayyaba Kiran
Tayyaba Kiran
MHMina Husain
Mina Husain
NHNusrat Husain
Nusrat Husain
Background: The evidence base for stigma in mental health largely originates from high-income countries. Aims: This study from Pakistan aimed to address the gap in literature on stigma from low- and middle-income countries. Method: This cross-sectional study surveyed 1470 adults from Karachi, Pakistan. Participants from three groups (healthcare professionals, healthcare students and the general public) completed the adapted Bogardus Social Distance Scale (SDS) as a measure of stigma. Results: All three groups reported higher scores of stigma toward mental disorders compared with physical disorders. SDS scores for mental illness in the general public were significantly higher than in healthcare students (mean difference (MD) 6.93, 95% CI 5.45–8.45, P < 0.001) and healthcare professionals (MD 6.93, 95% CI 5.48–8.38, P < 0.001). However, SDS scores between healthcare students and healthcare professionals were not significantly different (MD 0.003, 95% CI −1.14–1.14, P > 0.99). Being female was associated with lower stigma scores and being over the age of 30 years was associated with higher stigma scores. Conclusions: Stigma campaigns in Pakistan need to target the general population. However, evidence of negative attitudes toward mental illness in healthcare students and healthcare professionals supports the need for stronger emphasis on psychiatric education within undergraduate and postgraduate training in Pakistan.

1 October 2017 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
NHNusrat Husain
Nusrat Husain
FZFarah Zulqernain
Farah Zulqernain
LCLesley-Anne Carter
Lesley-Anne Carter
ICImran B. Chaudhry
Imran B. Chaudhry
BFBatool Fatima
Batool Fatima
ARAtif Rahman
Atif Rahman

6 December 2017 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
ICImran B. Chaudhry
Imran B. Chaudhry
Nasir MehmoodNasir Mehmood
Nasir Mehmood
RRRaza Ur Rehman
Raza Ur Rehman
AKAjmal Kazmi
Ajmal Kazmi
MHMunir Hamirani
Munir Hamirani
NHNusrat Husain
Nusrat Husain
Evidence for efficacy of cognitive-behavioural therapy (CBT) in treatment of schizophrenia is growing. CBT is effective and cost efficient in treating positive and negative symptoms. To effectively meet the needs of diverse cultural groups, CBT needs to be adapted to the linguistic, cultural and socioeconomic context. We aimed to assess the feasibility, efficacy and acceptability of a culturally adapted CBT for treatment of psychosis (CaCBTp) in a low-income country. Rater-blind, randomised, controlled trial of the use of standard duration CBT in patients with psychosis from a low-income country. Participants with a ICD-10 diagnosis of psychosis were assessed using Positive and Negative Syndrome Scale for Schizophrenia (PANSS), Psychotic Symptom Rating Scales (PSYRATS), and the Schedule for Assessment of Insight (SAI) (baseline, 3 months and 6 months). They were randomized into the intervention group (n = 18) and Treatment As Usual (TAU) group (n = 18). The intervention group received 12 weekly sessions of CaCBTp. The CaCBTp group had significantly lower scores on PANSS Positive (p = 0.02), PANSS Negative (p = 0.045), PANSS General Psychopathology (p = 0.008) and Total PANSS (p = 0.05) when compared to TAU at three months. They also had low scores on Delusion Severity Total (p = 0.02) and Hallucination Severity Total (p = 0.04) of PSYRATS, as well as higher scores on SAI (p = 0.01) at the same time point. At six months only the improvement in PANSS positive scores (p = 0.045) met statistical significance.. It is feasible to offer CaCBTp as an adjunct to TAU in patients with psychosis, presenting to services in a lower middle-income country. Clinicaltrials.gov identifier NCT02202694 (Retrospectively registered).

ANAnum Naz
Anum Naz
ANAmna Noureen
Amna Noureen
TKTayyaba Kiran
Tayyaba Kiran
MHMuhammad Ishrat Husain
Muhammad Ishrat Husain
AMAyesha Minhas
Ayesha Minhas
NCNasim Chaudhry
Nasim Chaudhry
Suicide is a serious global public health problem and the third leading cause of death in those 15–35 years old. Self-harm is the major predictor of future suicide attempts and completed suicide yet remains poorly understood. There is limited evidence on effective interventions for adolescents who present with self-harm. To identify and develop acceptable preventive and therapeutic interventions it is essential to understand the factors that contribute to self-harm and suicide in young people, in the context of their emotions, interpersonal difficulties, available support and prevention strategies. This qualitative study aimed at exploring the lived experiences of adolescents presenting with self-harm and their views about potential prevention strategies. Semi-structured interviews with 16 adolescents (12–18 years) presenting with a self-harm episode in a public hospital in Pakistan. A topic guide was developed to facilitate the interviews. The following themes emerged using the framework analysis; predisposing factors (interpersonal conflicts, emotional crisis etc.), regret and realization that self-harm is not the only option, perceived impact of self-harm, and suggestions for suicide prevention strategies (sharing, distraction techniques, involvement of family). This study may help in refining a contextual and culturally based explanatory model of self-harm in adolescents and in informing development of culturally acceptable interventions.

6 January 2021 in Children
Verified
Journal Article
Open access
PDF file
MHMuhammad Ishrat Husain
Muhammad Ishrat Husain
ICImran B. Chaudhry
Imran B. Chaudhry
AKAmeer Khoso
Ameer Khoso
Ming Wai WanMing Wai Wan
Ming Wai Wan
TKTayyaba Kiran
Tayyaba Kiran
NHNusrat Husain
Nusrat Husain
Background: Globally, paternal depression is a neglected and under-researched area. Aims: To feasibility test Learning Through Play Plus Dads (LTP+ Dads), a group parenting psychoeducation program adapted for depressed Pakistani fathers of children under 3 years of age. Methods: Fathers with depression were recruited in Karachi, Pakistan, for a pre-post feasibility study. Ten sessions of group LTP+ Dads were offered over three months. Clinical assessments were administered at baseline, three (end of intervention), and six (follow-up) months and included the Edinburgh Postnatal Depression Scale, 17-item Hamilton Depression Rating Scale, Brief Disability Questionnaire, Multidimensional Scale of Perceived Social Support, Euro-Qol-5 Dimensions, Rosenberg Self-esteem Scale, Parenting Stress Index, and Knowledge, Attitude and Practices questionnaire. Results: Of the 78 fathers approached, 34 consented to screening and 18 were eligible to participate. Participants had a mean age of 33 years, with a mean of 3.61 children. Most were unemployed and were from low-income households with low education backgrounds. The intervention was feasible and acceptable based on a recruitment rate of 100% of eligible participants and a 100% attendance rate for five of the 10 sessions. Fathers showed, on average, a reduction in depressive symptoms, an increase in most areas of knowledge, and positive attitudes about child development. Perceived social support, self-esteem, and functioning scores also increased. Conclusions: A low-cost, culturally adapted group intervention was found to be feasible and acceptable. Changes in depression, parenting-related, and other outcomes are promising and inform a future larger trial. Trial Registration: The trial was registered on Clinicaltrials.gov on 9 December 2020 (identifier: NCT04660253).